BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2820310)

  • 1. [Chemotherapy of high-risk trophoblastic neoplasia].
    Kawashima Y; Maeda M; Sugimura M
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2658-66. PubMed ID: 2820310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia].
    Wang YX; Zhang X; Guan YL; Jang AY; Long ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):87-90. PubMed ID: 15840285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of surgical resection of pulmonary metastasis of trophoblastic tumour].
    Ren T; Xiang Y; Yang XY; Wan XR; Zhang ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):418-21. PubMed ID: 12974086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of patients with trophoblastic tumors in the Academic Medical Center: 31 patients in 10 years, 1983-1992].
    Laan R; Bakker P; Lammes FB
    Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1829-34. PubMed ID: 7477506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gestational trophoblastic tumors and recent clinical information].
    Shimizu T; Yaegashi N
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor-prognosis gestational trophoblastic disease: an update.
    Surwit EA; Alberts DS; Christian CD; Graham VE
    Obstet Gynecol; 1984 Jul; 64(1):21-6. PubMed ID: 6204257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
    Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
    Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
    Surwit EA; Childers JM
    J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
    Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
    Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
    Newlands ES; Holden L; Seckl MJ; McNeish I; Strickland S; Rustin GJ
    J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
    Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
    Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of high-risk gestational trophoblastic disease.
    Surwit EA
    J Reprod Med; 1987 Sep; 32(9):657-62. PubMed ID: 2822919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
    Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
    Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
    Kohorn EI
    Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
    Wang S; An R; Han X; Zhu K; Xue Y
    Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.